254.37
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $254.37, with a volume of 892.61K.
It is up +1.54% in the last 24 hours and up +2.71% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$250.51
Open:
$251.35
24h Volume:
892.61K
Relative Volume:
1.13
Market Cap:
$21.29B
Revenue:
$12.71B
Net Income/Loss:
$435.50M
P/E Ratio:
49.39
EPS:
5.15
Net Cash Flow:
$843.20M
1W Performance:
+2.97%
1M Performance:
+2.71%
6M Performance:
+7.15%
1Y Performance:
+29.33%
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
LH
Labcorp Holdings Inc
|
254.37 | 20.68B | 12.71B | 435.50M | 843.20M | 5.15 |
![]()
TMO
Thermo Fisher Scientific Inc
|
403.66 | 151.80B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
193.08 | 135.27B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
524.86 | 41.36B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
114.94 | 31.50B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
147.90 | 24.01B | 15.50B | 1.33B | 2.16B | 7.34 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-02-25 | Initiated | Redburn Atlantic | Buy |
Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
Dec-10-24 | Resumed | Jefferies | Buy |
Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
Oct-01-24 | Initiated | Piper Sandler | Neutral |
Mar-25-24 | Upgrade | Argus | Hold → Buy |
Feb-26-24 | Initiated | Leerink Partners | Outperform |
Feb-09-24 | Initiated | Evercore ISI | In-line |
Jan-03-24 | Initiated | Barclays | Equal Weight |
Sep-06-23 | Initiated | HSBC Securities | Hold |
Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
Sep-19-22 | Downgrade | Argus | Buy → Hold |
Aug-22-22 | Resumed | Morgan Stanley | Overweight |
Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
Jan-11-21 | Upgrade | Argus | Hold → Buy |
Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Jun-02-20 | Resumed | Deutsche Bank | Buy |
May-15-20 | Upgrade | Mizuho | Neutral → Buy |
Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
Jan-08-20 | Initiated | Wells Fargo | Overweight |
Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
Jan-17-19 | Initiated | UBS | Buy |
Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
Oct-30-18 | Downgrade | Argus | Buy → Hold |
Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
Oct-19-18 | Resumed | BofA/Merrill | Buy |
Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Should You Continue to Hold Labcorp Stock in Your Portfolio? - TradingView
Fortrea Faces Investor Suit Over Post-Labcorp Financial Woes - Law360
FTRE INVESTOR ALERT: Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Fortrea Class Action Lawsuit - The Malaysian Reserve
FTRE Stockholder Alert: Robbins LLP Informs Investors of the Fortrea Holdings, Inc. Class Action Lawsuit - Morningstar
ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage - Yahoo Finance
Labcorp Adds New Tests for Solid Tumors, Hematologic Malignancies - marketscreener.com
Labcorp Expands Oncology Portfolio to Improve Patient Care, Advance Cancer Research - marketscreener.com
Labcorp Expands Oncology Portfolio to Improve Patient Care and A - GuruFocus
Labcorp (LH) Expands Precision Oncology Portfolio with New Offerings | LH Stock News - GuruFocus
Labcorp Revolutionizes Cancer Care: New Test Portfolio Promises Faster Treatment Decisions - Stock Titan
Why Is Labcorp (LH) Up 2.5% Since Last Earnings Report? - Yahoo Finance
Are Investors Undervaluing Labcorp (LH) Right Now? - Yahoo Finance
Labcorp Holdings Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Labcorp Holdings Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
Should You Buy Labcorp Holdings Inc. (NYSE:LH) For Its Upcoming Dividend? - Yahoo
Labcorp (LH) Secures $117.03M Contract Modification for Laborato - GuruFocus
Chart of the Day: LabCorp Isn't Passing the Growth Test Yet - TheStreet Pro
Mizuho lifts LabCorp stock target to $274, keeps Outperform rating By Investing.com - Investing.com Canada
Labcorp Holdings (NYSE:LH) Partners With Frame to Enhance Fertility Testing Access - Yahoo Finance
Mizuho lifts LabCorp stock target to $274, keeps Outperform rating - Investing.com
Mizuho Adjusts Price Target on Labcorp Holdings to $274 From $264, Maintains Outperform Rating - marketscreener.com
Labcorp Holdings Inc. (LH) Announces Approval of 2025 Incentive and Stock Purchase Plans - GuruFocus
Labcorp shareholders approve new incentive plans By Investing.com - Investing.com Nigeria
Labcorp Holdings Approves Key Proposals at Annual Meeting - TipRanks
Labcorp shareholders approve new incentive plans - Investing.com
Here's Why Labcorp (LH) is a Strong Value Stock - Yahoo Finance
Baird Adjusts Price Target on Labcorp Holdings to $268 From $267, Maintains Outperform Rating - marketscreener.com
Here's Why Labcorp (LH) is a Strong Momentum Stock - Yahoo Finance
Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight - GlobeNewswire Inc.
Zacks Industry Outlook Highlights Cardinal Health, Labcorp And Align Technology - Barchart.com
Zacks Industry Outlook Highlights Cardinal Health, Labcorp and Align Technology - Yahoo Finance
Labcorp Holdings CEO Adam Schechter sells $1.52 million in stock By Investing.com - Investing.com South Africa
Labcorp Holdings CEO Adam Schechter sells $1.52 million in stock - Investing.com Australia
Insider Sell: Adam Schechter Sells Shares of Labcorp Holdings In - GuruFocus
Insider Sell: Adam Schechter Sells Shares of Labcorp Holdings Inc (LH) - GuruFocus
Labcorp Holdings Insider Sold Shares Worth $1,518,497, According to a Recent SEC Filing - marketscreener.com
LH Q1 Earnings Call: Labcorp Grows Revenue but Misses Expectations, Raises Adjusted EPS Guidance - Yahoo Finance
Labcorp Holdings (LH) Price Target Raised by Truist Securities | - GuruFocus
Labcorp (LH) Price Target Raised by Truist Analyst to $290 | LH Stock News - GuruFocus
Labcorp to Webcast Its Annual Meeting of Shareholders May 15 - The Malaysian Reserve
LabCorp Holdings Inc. (LH) Files Form 8-K with SEC - GuruFocus
Labcorp Holdings to Webcast Annual Shareholder Meeting - TipRanks
Justices' Labcorp Questions Explore Class Cert. Tensions - Law360
Labcorp Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72 - Yahoo Finance
Most Shareholders Will Probably Agree With Labcorp Holdings Inc.'s (NYSE:LH) CEO Compensation - simplywall.st
Labcorp Holdings' (NYSE:LH) Earnings May Just Be The Starting Point - Yahoo Finance
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):